share_log
Reuters ·  Mar 11 12:33
Aprea Therapeutics Announces Agreement With Md Anderson Cancer Center to Explore Apr-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (Hnscc)
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 250
Write a comment